Heather Kelly-Nix, PharmD

The combination of TARCEVA and a statin may increase the potential for statin-induced myopathy, including rhabdomyolysis, which was observed rarely. In a Phase Ib study, there were no significant effects of gemcitabine on the pharmacokinetics of TARCEVA nor were there significant effects of TARCEVA on the pharmacokinetics of gemcitabine. ................
................

In order to avoid copyright disputes, this page is only a partial summary.